Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.39
-0.13 (-1.99%)
At close: Nov 13, 2026, 4:00 PM EST
6.51
+0.12 (1.88%)
After-hours: Nov 13, 2026, 7:53 PM EST
Immatics Market Cap
Immatics has a market cap or net worth of $873.45 million as of November 13, 2026. It is the 10,725th most valuable company in the world and the 2,311th biggest in the United States. Its market cap has decreased by 32.66% in one year.
Market Cap
873.45M
Enterprise Value
575.17M
1-Year Change
-32.66%
Global Rank
Country Rank
#2,311 United States
Category
ChartMarket Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $873.45M, an increase of 406.35%. That is a compound annual growth rate of 22.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 873.45M | -37.95% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 927.18M |
| Odyssey Therapeutics | 917.59M |
| Corvus Pharmaceuticals | 901.73M |
| MeiraGTx Holdings | 899.12M |
| Pharming Group | 894.35M |
| City Therapeutics | 885.17M |
| Latigo Biotherapeutics | 868.52M |
| Inventiva | 838.34M |